Is CGC Worth Buying in 2026?

Canopy Growth Corporation Common Shares

STOCK MEDICINAL CHEMICALS & BOTANICAL PRODUCTS Updated 2026-06-14

Here’s whether Canopy Growth Corporation Common Shares (CGC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: 50-day MA is rising (+1.61% over 10 days); RSI 40 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); weak 1-year return of -34.6%. Currently 58.0% off its 52-week high. Score: -2/7.

Ready to act on this? 📈 Trade on Webull

CGC is trading below its 200-day MA ($1.20) — a key warning sign the longer-term trend is under pressure. An RSI of 40.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -34.6% compares to +22.9% for SPY (trailed the market by 57.5%). The current 58.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $6,536 today
vs. S&P 500 (SPY) — same period trailed market by 57.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.20)
Above 50-day MA ($1.09)
RSI(14) neutral zone (30–70) — currently 40.0
Positive return (-34.6%)
!Within 10% of period high (−58.0%)
Period Range $1.00
$0.84 $2.38
RSI (14) 40.0
0 · OversoldOverbought · 100

Key Metrics

Price$1.00
Period Return-34.6%
Period High$2.38
Period Low$0.84
Drawdown−58.0%
MA-50$1.09
MA-200$1.20
RSI (14)40.0
Avg Volume (30d)7.1M
vs. SPYtrailed by 57.5%
Return Rank#985 of 1246

Trade CGC

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers